# Haemonetics (HAE) — Analyst Forecast

HAE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/hae/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 9 | 3 | 0 | 12 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $86.00 | $123.29 | $140.00 | 7 |

Last price $121.29 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 9, 2026 | Mizuho | Maintained | Outperform | $140.00 |
| Oct 9, 2026 | Barrington Research | Maintained | Outperform | $140.00 |
| Oct 8, 2026 | BTIG | Maintained | Buy | $130.00 |
| Sep 17, 2026 | Citigroup | Upgraded | Neutral → Buy | $123.00 |
| Sep 3, 2026 | Raymond James | Maintained | Outperform | $125.00 |
| Aug 21, 2026 | Baird | Maintained | Outperform | $119.00 |
| Aug 19, 2026 | Barrington Research | Maintained | Outperform | $118.00 |
| Aug 18, 2026 | BTIG | Maintained | Buy | $110.00 |
| Aug 7, 2026 | JP Morgan | Maintained | Neutral | $86.00 |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | $92.00 |
| Aug 6, 2026 | BTIG | Maintained | Buy | $96.00 |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | $90.00 |
| Jun 26, 2026 | BTIG | Maintained | Buy | $84.00 |
| Jun 17, 2026 | BTIG | Maintained | Buy | $84.00 |
| Jun 15, 2026 | Mizuho | Maintained | Outperform | $85.00 |
| May 28, 2026 | Citigroup | Maintained | Neutral | $70.00 |
| May 22, 2026 | B of A Securities | Upgraded | Neutral → Buy | $80.00 |
| May 12, 2026 | Barrington Research | Maintained | Outperform | $89.00 |
| May 8, 2026 | JP Morgan | Maintained | Neutral | $62.00 |
| Apr 13, 2026 | Mizuho | Maintained | Outperform | $70.00 |

## Frequently Asked Questions

### What is the price target for HAE stock?

The average 12-month analyst price target for Haemonetics (HAE) is $123.29, with a high estimate of $140.00 and a low of $86.00, across 7 analysts.

### Is HAE a buy, sell, or hold?

Analysts covering Haemonetics currently average a Buy rating: 9 buy, 3 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for HAE?

The average price target of $123.29 implies 1.65% upside from the last price of $121.29.

### What is the latest analyst rating on HAE?

On Oct 9, 2026, Mizuho maintained Haemonetics at Outperform with a price target of $140.00.

## Similar Stocks

- [PODD](https://www.lighthorse.io/tickers/podd) — Insulet Corporation - Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [QTRX](https://www.lighthorse.io/tickers/qtrx) — Quanterix Corporation - Common Stock
- [SIBN](https://www.lighthorse.io/tickers/sibn) — SI-BONE, Inc. - Common Stock
- [PEN](https://www.lighthorse.io/tickers/pen) — Penumbra, Inc. Common Stock
- [ZBH](https://www.lighthorse.io/tickers/zbh) — Zimmer Biomet Holdings, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [LNTH](https://www.lighthorse.io/tickers/lnth) — Lantheus Holdings, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).